184 related articles for article (PubMed ID: 34933422)
1. [Analysis of the factors influencing the elimination strategies with the current status of diagnosis and treatment of hepatitis C in hospital].
He N; Hao S; Feng G; Gao J; Kong FJ; Ren ZX; Xu MQ; Yang YQ
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1053-1058. PubMed ID: 34933422
[No Abstract] [Full Text] [Related]
2. Multi-disciplinary cooperation for the micro-elimination of hepatitis C in China: a hospital-based experience.
Zheng L; Zhang X; Nian Y; Zhou W; Li D; Wu Y
BMC Gastroenterol; 2023 Nov; 23(1):386. PubMed ID: 37951862
[TBL] [Abstract][Full Text] [Related]
3. The Prevalence of HCV Infection and Risk Factors in a Hospital- Based Population Screening, a First Step to the Micro-Elimination of HCV Infection in Medical Institutions from Romania - Results of the HepC ALERT Study.
Gheorghe L; Iacob S; Csiki IE; Huiban L; Cojocaru M; Cojocariu C; Nemteanu R; Girleanu I; Sirli R; Singeap AM; Pop C; Dumitrascu DL; Vadan R; Iacob R; Diculescu M; Trifan A; Sporea I; Gheorghe C
J Gastrointestin Liver Dis; 2020 Dec; 29(4):587-593. PubMed ID: 33331354
[TBL] [Abstract][Full Text] [Related]
4. Emergency department targeted screening for hepatitis C does not improve linkage to care.
Houri I; Horowitz N; Katchman H; Weksler Y; Miller O; Deutsch L; Shibolet O
World J Gastroenterol; 2020 Aug; 26(32):4878-4888. PubMed ID: 32921964
[TBL] [Abstract][Full Text] [Related]
5. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.
Mostafa A; Ebeid FSE; Khaled B; Ahmed RHM; El-Sayed MH
Trop Med Int Health; 2020 Jul; 25(7):850-860. PubMed ID: 32306545
[TBL] [Abstract][Full Text] [Related]
6. Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions.
Rosato V; Kondili LA; Nevola R; Perillo P; Mastrocinque D; Aghemo A; Claar E
Viruses; 2022 May; 14(5):. PubMed ID: 35632837
[No Abstract] [Full Text] [Related]
7. Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea.
Lee JS; Choi HJ; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
J Gastroenterol Hepatol; 2021 Sep; 36(9):2479-2485. PubMed ID: 33788314
[TBL] [Abstract][Full Text] [Related]
8. [A survey of the current status of research on the diagnosis and treatment of hepatitis C virus antibody-positive pregnant women].
Cai M; Han GR; Yue X; Ding Y; Wang Y; Li QR
Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):741-745. PubMed ID: 36038344
[No Abstract] [Full Text] [Related]
9. Hepatitis C screening in hospitals: find the missing patients.
Liu L; Xu H; Hu Y; Shang J; Jiang J; Yu L; Zhao C; Zhang D; Zhang X; Li J; Li W; Wu Y; Hu D; Wang X; Zhao Q; Zhang Q; Luo W; Chen J; Zhang D; Zhou W; Niu J
Virol J; 2019 Apr; 16(1):47. PubMed ID: 30992019
[TBL] [Abstract][Full Text] [Related]
10. Dual strategy involving hospital-based study and community-based screening to eliminate hepatitis C in remote areas.
Chen CH; Hsu NT; Chen IC; Chang TS; Cheng S; Cheng SY; Chen HM; Harn MR; Liu CK; Yang MT; Lu SL; Tseng CM; Lu SN
J Formos Med Assoc; 2024 May; 123(5):613-619. PubMed ID: 38195318
[TBL] [Abstract][Full Text] [Related]
11. Elimination of hepatitis C in a hospital characterized by infectious diseases.
Han Y; Zheng M; Meng H; Han J; Chen J; Wang Y
Front Public Health; 2023; 11():1093578. PubMed ID: 37006527
[TBL] [Abstract][Full Text] [Related]
12. Assessment of HCV-RNA test results and access rates to antiviral treatment in patients with anti-HCV positivity-a 10-year analysis.
Türkoğlu E; Parlak Z; Barut HŞ
Turk J Med Sci; 2022 Dec; 52(6):1984-1990. PubMed ID: 36945985
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of guideline-defined hepatitis C screening strategies within the 'Check-Up35+' examination in the primary care setting.
Petroff D; Wolffram I; Bätz O; Jedrysiak K; Kramer J; Berg T; Wiegand J
Liver Int; 2023 Apr; 43(4):785-793. PubMed ID: 36621849
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and characteristics of hepatitis C virus infection in Shenyang City, Northeast China, and prediction of HCV RNA positivity according to serum anti-HCV level: retrospective review of hospital data.
Li Y; Zhao L; Geng N; Zhu W; Liu H; Bai H
Virol J; 2020 Mar; 17(1):36. PubMed ID: 32178702
[TBL] [Abstract][Full Text] [Related]
15. Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study.
Yen HH; Su PY; Liu II; Zeng YH; Huang SP; Hsu YC; Hsu PK; Chen YY
BMC Gastroenterol; 2021 May; 21(1):209. PubMed ID: 33964873
[TBL] [Abstract][Full Text] [Related]
16. Hospital-based screening outperforms primary care screening as a means of achieving hepatitis C virus micro-elimination.
Fernández-García CE; Gallego-Galiana J; Solís-Muñoz PA; Del Pozo-Maroto E; Domínguez-Alcón L; Tobar-Izquierdo M; Sáez A; Rodríguez de Cía J; Magaña-Sánchez A; Real-Martínez Y; García-Buey L; González-Moreno L; Caldas-Álvarez M; Cardeñoso-Domingo LM; González-Gamarra A; Salvador-Calvo A; González-Rodríguez Á; García-Monzón C
Infect Dis Now; 2024 Mar; 54(2):104855. PubMed ID: 38309646
[TBL] [Abstract][Full Text] [Related]
17. Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey.
Çelen MK; Ertürk Şengel B; Kaya Ş; Demirtürk N; Azap A; Pullukçu H; Eroğlu E; Yıldırım F; Barut HŞ; Zerdali E; Sağmak Tartar A; Mete AÖ; Şahin AM; Mutay Suntur B; Sarı ND; Yılmaz E; Candevir A; Şimşek F; İnan D; Akhan S; Asan A; Günal Ö; Ural O; Parlak M; Çabalak M; Nazik S; Hızel K; Kınıklı S; Beştepe Dursun Z; Batırel A; Mermutluoğlu Ç
J Infect Dev Ctries; 2024 Mar; 18(3):441-449. PubMed ID: 38635621
[TBL] [Abstract][Full Text] [Related]
18. Differences in inpatient and outpatient hepatitis C virus prevalence and linkage to care rates in a safety net hospital hepatitis C screening program.
Veeramachaneni H; Park B; Blakely D; Palacio A; Darby R; Fluker SA; Lyles RH; Miller LS
J Gastroenterol Hepatol; 2021 Aug; 36(8):2285-2291. PubMed ID: 33724551
[TBL] [Abstract][Full Text] [Related]
19. Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study.
Kileng H; Gutteberg T; Goll R; Paulssen EJ
BMC Infect Dis; 2019 Feb; 19(1):189. PubMed ID: 30808290
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil.
Carvalho-Louro DM; Soares EB; Trevizoli JE; Marra TMG; da Cunha ALR; Rodrigues MP; Carvalho-Furtado ACL; Dos Santos BTA; de Assis da Rocha Neves F
BMC Infect Dis; 2020 Feb; 20(1):114. PubMed ID: 32041537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
